A randomised, double-blind, dose-finding, phase II multicentre study of ODX in the treatment of patients with castration-resistant prostate cancer and skeletal metastases

Autor: Thellenberg-Karlsson, Camilla, Vjaters, Egils, Kase, Marju, Tammela, Teuvo, Ojamaa, Kristiina, Norming, Ulf, Nyman, Claes, Andersson, Sven-Olof, Hublarovs, Oleg, Marquez-Holmberg, Marcela, Castellanos, Enrique, Ullen, Anders, Holmberg, Anders, Nilsson, Sten
Zdroj: In European Journal of Cancer March 2023 181:198-207
Databáze: ScienceDirect
Externí odkaz: